Skip to main content
NCBI home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2022 Feb 4;65(4):512–524. [Article in German] doi: 10.1007/s00103-022-03490-6

Malaria

Stellungnahmen des Arbeitskreises Blut des Bundesministeriums für Gesundheit

PMCID: PMC8814801  PMID: 35119479

The content is available as a PDF (370.1 KB).

Literatur

  • 1.WHO Malaria Report 2020
  • 2.Lee K-S, Divis PCS, Zakaria SK, et al. Plasmodium knowlesi: reservoir hosts and tracking the emergence in humans and macaques. PLoS Pathog. 2011;7:e1002015. doi: 10.1371/journal.ppat.1002015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Kuvin SF, Beye HK, Stohlmann F, Contactos PG, Coatney GR. Malaria in man. Infection by Plasmodium vivax and the B strain of Plasmodium cynomolgi. JAMA. 1963;184:1018–1020. doi: 10.1001/jama.1963.73700260001010. [DOI] [PubMed] [Google Scholar]
  • 4.Contactos PG, Elder HA, Coatney GR, Genther C. Man to man transfer of two strains of Plasmodium cynomolgi by mosquito bite. Am J Trop Med Hyg. 1962;11:186–193. doi: 10.4269/ajtmh.1962.11.186. [DOI] [PubMed] [Google Scholar]
  • 5.Bennet GF, Warren M. Transmission of a new strain of Plasmodium cynomogli to man. J Parasitol. 1965;51:79–80. doi: 10.2307/3275651. [DOI] [PubMed] [Google Scholar]
  • 6.Most H. Plasmodium cynomolgi malaria: accidental human infection. Am J Trop Med Hyg. 1973;22:157–158. doi: 10.4269/ajtmh.1973.22.157. [DOI] [PubMed] [Google Scholar]
  • 7.Brasil P, Zalis MG, de Pina-Costa A, et al. Outbreak of human malaria caused by Plasmodium simium in the Atlantic Forest in Rio de Janeiro. A molecular epidemiological investigation. Lancet Glob Health. 2017;5:e1038–e1046. doi: 10.1016/S2214-109X(17)30333-9. [DOI] [PubMed] [Google Scholar]
  • 8.Lalremruata A, Magris M, Vivas-Martínez S, et al. Natural infection of Plasmodium brasilianum in humans: Man and monkey share quartan malaria parasites in the Venezuelan Amazon. EBioMedicine. 2015;2:1186–1192. doi: 10.1016/j.ebiom.2015.07.033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Raja NT, Hu TH, Zainudin R, Lee KS, Perkins SL, Singh B. Malaria parasites of long-tailed macaques in Sarawak, Malaysian Borneo: a novel species and demographic and evolutionary histories. BMC Evol Biol. 2018;18:49. doi: 10.1186/s12862-018-1170-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Maeno Y. Molecular epidemiology of mosquitoes for the transmission of forest malaria in south-central Vietnam. Trop Med Health. 2017;45:27. doi: 10.1186/s41182-017-0065-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Ramasamy R. Zoonotic malaria—global overview and research and policy needs. Front Public Health. 2014;2:123. doi: 10.3389/fpubh.2014.00123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Ta TH, Hisam S, Lanza M, Jiram AI, Ismail N, Rubio JM. First case of a naturally acquired human infection with Plasmodium cynomolgi. Malar J. 2014;13:68. doi: 10.1186/1475-2875-13-68. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Hartmeyer GN, Stensvold CR, Fabricius T, et al. Plasmodium cynomolgi as Cause of Malaria in Tourist to Southeast Asia, 2018. Emerging Infect Dis. 2019;25:1936–1939. doi: 10.3201/eid2510.190448. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Grignard L, Shah S, Chua TH, William T, Drakeley CJ, Fornace KM. Natural Human Infections With Plasmodium cynomolgi and Other Malaria Species in an Elimination Setting in Sabah, Malaysia. J Infect Dis. 2019;220:1946–1949. doi: 10.1093/infdis/jiz397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Richter J, Franken G, Holtfreter MC, Walter S, Labisch A, Mehlhorn H. Clinical implications of a gradual dormancy concept in malaria. Parasitol Res. 2016;115:2139–2148. doi: 10.1007/s00436-016-5043-0. [DOI] [PubMed] [Google Scholar]
  • 16.Metzger W, Vivas-Martínez S. Plasmodium brasilianum ist Plasmodium malariae: Malaria-quartana-Parasiten im venezolanischen Amazonas. Flug U Reisemed. 2017;24:285–291. doi: 10.1055/s-0043-122728. [DOI] [Google Scholar]
  • 17.Mordmüller B, Supan C, Sim KL, et al. Direct venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose-finding trial in two centres. Malar J. 2015;14:117. doi: 10.1186/s12936-015-0628-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Lau YL, Tan LH, Chin LC, Fong MY, Noraishah MA-A, Rohela M. Plasmodium knowlesi reinfection in human. Emerging Infect Dis. 2011;17:1314–1315. doi: 10.3201/eid1707.101295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Nolder D, Oguike MC, Maxwell-Scott H, et al. An observational study of malaria in British travellers: Plasmodium ovale wallikeri and Plasmodium ovale curtisi differ significantly in the duration of latency. Bmj Open. 2013 doi: 10.1136/bmjopen-2013-002711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Grande R, Antinori S, Meroni L, Menegon M, Severini C. A case of Plasmodium malariae recurrence: recrudescence or reinfection? Malar J. 2019;18:169. doi: 10.1186/s12936-019-2806-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Milner DA. Malaria Pathogenesis. Cold Spring Harb Perspect Med. 2018 doi: 10.1101/cshperspect.a025569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Vinetz JM, Li J, McCutchan TF, Kaslow DC. Plasmodium malariae infection in an asymptomatic 74-year-old Greek woman with splenomegaly. N Engl J Med. 1998;338:367–371. doi: 10.1056/NEJM199802053380605. [DOI] [PubMed] [Google Scholar]
  • 23.Millar SB, Cox-Singh J. Human infections with Plasmodium knowlesi—zoonotic malaria. Clin Microbiol Infect. 2015;21:640–648. doi: 10.1016/j.cmi.2015.03.017. [DOI] [PubMed] [Google Scholar]
  • 24.Singh B, Daneshvar C. Human infections and detection of Plasmodium knowlesi. Clin Microbiol Rev. 2013;26:165–184. doi: 10.1128/CMR.00079-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Mouchet J. Airport malaria : a rare disease still poorly understood. Euro Surveill. 2000;5:75–76. doi: 10.2807/esm.05.07.00016-en. [DOI] [PubMed] [Google Scholar]
  • 26.European Center for Disease Prevention and Control (2020) Malaria. Annual Epidemiological Report for 2018, Stockholm
  • 27.European Center for Disease Prevention and Control . Hospital-acquired malaria infections in the European Union. Stockholm, Sweden: Rapid Risk Assessment; 2018. [Google Scholar]
  • 28.ECDC (2019) Malaria Annual Epidemiological Report for 2017. Surveillance Report
  • 29.Vygen-Bonnet S, Stark K. Changes in malaria epidemiology in Germany, 2001–2016: a time series analysis. Malar J. 2018;17:28. doi: 10.1186/s12936-018-2175-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Falkenhorst G, Enkelmann J, Lachmann R, et al. Reiseassoziierte Krankheiten 2018. 2019. [Google Scholar]
  • 31.Falkenhorst G, Enkelmann J, Lachmann R, et al. Zur Situation bei wichtigen Infektionskrankheiten – Reiseassoziierte Krankheiten 2019. 2020. [Google Scholar]
  • 32.Fischer L. Einheimische Malaria und Anophelismus in der Nachkriegszeit. Dtsch Med Wochenschr. 1948;73:515–518. doi: 10.1055/s-0028-1118201. [DOI] [Google Scholar]
  • 33.Krüger A, Rech A, Su XZ, Tannich E. Two cases of autochthonous Plasmodium falciparum malaria in Germany with evidence for local transmission by indigenous Anopheles plumbeus. Trop Med Int Health. 2001;6:983–985. doi: 10.1046/j.1365-3156.2001.00816.x. [DOI] [PubMed] [Google Scholar]
  • 34.Gruell H, Hamacher L, Jennissen V, et al. On Taking a Different Route: An Unlikely Case of Malaria by Nosocomial Transmission. Clin Infect Dis. 2017;65:1404–1406. doi: 10.1093/cid/cix520. [DOI] [PubMed] [Google Scholar]
  • 35.Ahmadpour E, Foroutan-Rad M, Majidiani H, et al. Transfusion-Transmitted Malaria: A Systematic Review and Meta-analysis. Open Forum Infect Dis. 2019;6:ofz283. doi: 10.1093/ofid/ofz283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Deutsche Gesellschaft für Tropenmedizin und Internationale Gesundheit (2021) S1-Leitlinie 042-001: Diagnostik und Therapie der Malaria, 042/001
  • 37.Moody A. Rapid diagnostic tests for malaria parasites. Clin Microbiol Rev. 2002;15:66–78. doi: 10.1128/cmr.15.1.66-78.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Milne LM, Kyi MS, Chiodini PL, Warhurst DC. Accuracy of routine laboratory diagnosis of malaria in the United Kingdom. J Clin Pathol. 1994;47:740–742. doi: 10.1136/jcp.47.8.740. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.WHO (2017) Malaria rapid diagnostic test performance. Results of WHO product testing of malaria RDTs: round 7 (2015–2016)
  • 40.Gendrot M, Fawaz R, Dormoi J, Madamet M, Pradines B. Genetic diversity and deletion of Plasmodium falciparum histidine-rich protein 2 and 3: a threat to diagnosis of P. falciparum malaria. Clin Microbiol Infect. 2019;25:580–585. doi: 10.1016/j.cmi.2018.09.009. [DOI] [PubMed] [Google Scholar]
  • 41.Pasquier G, Azoury V, Sasso M, et al. Rapid diagnostic tests failing to detect infections by Plasmodium falciparum encoding pfhrp2 and pfhrp3 genes in a non-endemic setting. Malar J. 2020;19:179. doi: 10.1186/s12936-020-03251-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Kim J, Cao XE, Finkelstein JL, Cárdenas WB, Erickson D, Mehta S. A two-colour multiplexed lateral flow immunoassay system to differentially detect human malaria species on a single test line. Malar J. 2019;18:313. doi: 10.1186/s12936-019-2957-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Reiter-Owona I, Hoerauf A (2012) Zur Wertigkeit eines spezifischen Malaria-Schnelltests (NADAL®Malaria4 species) bei der Untersuchung von Personen mit fieberhaftem Infekt nach Auslandsaufenthalt Bd. 1. , Berlin
  • 44.Plucinski MM, Dimbu PR, Fortes F, et al. Posttreatment HRP2 Clearance in Patients with Uncomplicated Plasmodium falciparum Malaria. J Infect Dis. 2018;217:685–692. doi: 10.1093/infdis/jix622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.WHO, FIND, CDC (2018) Malaria rapid diagnostic test performance. Results of WHO product testing of malaria RDTs: round 8. (2016–2018)
  • 46.WHO (2020) WHO list of prequalified in vitro diagnostic products. https://extranet.who.int/pqweb/vitro-diagnostics/vitro-diagnostics-lists. Zugegriffen: 19. Jan. 2022
  • 47.Mathison BA, Pritt BS. Update on Malaria Diagnostics and Test Utilization. J Clin Microbiol. 2017;55:2009–2017. doi: 10.1128/JCM.02562-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Vasoo S, Pritt BS. Molecular diagnostics and parasitic disease. Clin Lab Med. 2013;33:461–503. doi: 10.1016/j.cll.2013.03.008. [DOI] [PubMed] [Google Scholar]
  • 49.Conway DJ. Molecular epidemiology of malaria. Clin Microbiol Rev. 2007;20:188–204. doi: 10.1128/CMR.00021-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Hopkins H, González IJ, Polley SD, et al. Highly sensitive detection of malaria parasitemia in a malaria-endemic setting: performance of a new loop-mediated isothermal amplification kit in a remote clinic in Uganda. J Infect Dis. 2013;208:645–652. doi: 10.1093/infdis/jit184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Divis PCS, Shokoples SE, Singh B, Yanow SK. A TaqMan real-time PCR assay for the detection and quantitation of Plasmodium knowlesi. Malar J. 2010;9:344. doi: 10.1186/1475-2875-9-344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Seed CR, Kitchen A, Davis TME. The current status and potential role of laboratory testing to prevent transfusion-transmitted malaria. Transfus Med Rev. 2005;19:229–240. doi: 10.1016/j.tmrv.2005.02.004. [DOI] [PubMed] [Google Scholar]
  • 53.Brouwer EE, van Hellemond JJ, van Genderen PJ, et al. A case report of transfusion-transmitted Plasmodium malariae from an asymptomatic non-immune traveller. Malar J. 2013;12:439. doi: 10.1186/1475-2875-12-439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Holtzclaw A, Mrsic Z, Managbanag J, Calvano T, Colombo C. Transfusion-transmitted malaria not preventable by current blood donor screening guidelines: a case report. Transfusion. 2016;56:2221–2224. doi: 10.1111/trf.13680. [DOI] [PubMed] [Google Scholar]
  • 55.Scuracchio P, Vieira SD, Dourado DA, et al. Transfusion-transmitted malaria: case report of asymptomatic donor harboring Plasmodium malariae. Rev Inst Med Trop Sao Paulo. 2011;53:55–59. doi: 10.1590/s0036-46652011000100010. [DOI] [PubMed] [Google Scholar]
  • 56.O’Brien SF, Delage G, Seed CR, et al. The Epidemiology of Imported Malaria and Transfusion Policy in 5 Nonendemic Countries. Transfus Med Rev. 2015;29:162–171. doi: 10.1016/j.tmrv.2015.03.004. [DOI] [PubMed] [Google Scholar]
  • 57.Wilkins PP, Nutman TB. Immunological and Molecular Approaches for the Diagnosis of Parasitic Infections. In: Detrick B, Schmitz JL, Hamilton RG, editors. Manual of molecular and clinical laboratory immunology. 8. Washington: ASM Press; 2016. pp. 486–502. [Google Scholar]
  • 58.Mangano VD, Perandin F, Tiberti N, et al. Risk of transfusion-transmitted malaria: evaluation of commercial ELISA kits for the detection of anti-Plasmodium antibodies in candidate blood donors. Malar J. 2019;18:17. doi: 10.1186/s12936-019-2650-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Garfield MD, Ershler WB, Maki DG. Malaria transmission by platelet concentrate transfusion. JAMA. 1978;240(21):2285–2286. doi: 10.1001/jama.1978.03290210067033. [DOI] [PubMed] [Google Scholar]
  • 60.Dover AS, Guinee VF. Malaria transmission by leukocyte component therapy. JAMA. 1971;217(12):1701–1702. doi: 10.1001/jama.1971.03190120067017. [DOI] [PubMed] [Google Scholar]
  • 61.Lazner E, Newhouser E. Studies on the transmission of malaria by blood transfusions. Am J Med Sci. 1943;204:141–146. doi: 10.1097/00000441-194308000-00001. [DOI] [Google Scholar]
  • 62.Slinger R, Giulivi A, Bodie-Collins M, et al. Transfusion-transmitted malaria in Canada. Cmaj. 2001;164(3):377–379. [PMC free article] [PubMed] [Google Scholar]
  • 63.Bruce-Chwatt LJ. TRANSFUSION MALARIA. Lancet. 1985;8(5):90314–90319. doi: 10.1016/S0140-6736. [DOI] [PubMed] [Google Scholar]
  • 64.Boyd FM. Malariology. W.B. Saunders Company; 1949. [Google Scholar]
  • 65.Ashley EA, White NJ. The duration of Plasmodium falciparum infections. Malar J. 2014;13:500. doi: 10.1186/1475-2875-13-500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Besson P, Robert J, Reviron J, Richardlenoble D, Gentilini M. A propos de deux observations de paludisme transfusionnel. Essai de prévention associant un test d’immunofluorescence indirecte aux critères de sélection clinique. Rev Fr Transfus Immunohematol. 1976;19:369–373. doi: 10.1016/S0338-4535(76)80076-1. [DOI] [PubMed] [Google Scholar]
  • 67.Nahlen BL, Lobel HO, Cannon SE, Campbell CC. Reassessment of blood donor selection criteria for United States travelers to malarious areas. Transfusion. 1991;31:798–804. doi: 10.1046/j.1537-2995.1991.31992094665.x. [DOI] [PubMed] [Google Scholar]
  • 68.Mungai M, Tegtmeier G, Chamberland M, Parise M. Transfusion-transmitted malaria in the United States from 1963 through 1999. N Engl J Med. 2001;344:1973–1978. doi: 10.1056/NEJM200106283442603. [DOI] [PubMed] [Google Scholar]
  • 69.de Freitas DRC, Gomes LT, Fontes CJF, Tauil PL, Pang LW, Duarte EC. Sensitivity of nested-PCR for plasmodium detection in pooled whole blood samples and its usefulness to blood donor screening in endemic areas. Transfus Apher Sci. 2014;50:242–246. doi: 10.1016/j.transci.2014.01.016. [DOI] [PubMed] [Google Scholar]
  • 70.Batista-Dos-Santos SA, Freitas DRC, Raiol M, et al. Strategy to improve malaria surveillance system preventing transfusion-transmitted malaria in blood banks using molecular diagnostic. Malar J. 2018;17:344. doi: 10.1186/s12936-018-2486-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Kitchen AD, Barbara JAJ, Hewitt PE. Documented cases of post-transfusion malaria occurring in England: a review in relation to current and proposed donor-selection guidelines. Vox Sang. 2005;89:77–80. doi: 10.1111/j.1423-0410.2005.00661.x. [DOI] [PubMed] [Google Scholar]
  • 72.Alho RM, Machado KVA, Val FFA, et al. Alternative transmission routes in the malaria elimination era: an overview of transfusion-transmitted malaria in the Americas. Malar J. 2017;16:78. doi: 10.1186/s12936-017-1726-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Bruce-Chwatt LJ. Transfusion malaria revisited. Trop Dis Bull. 1982;79(10):827–840. [PubMed] [Google Scholar]
  • 74.Bruce-Chwatt LJ. Blood transfusion and tropical disease. Trop Dis Bull. 1972;69(9):825–862. [PubMed] [Google Scholar]
  • 75.Verra F, Angheben A, Martello E, Giorli G, Perandin F, Bisoffi Z. A systematic review of transfusion-transmitted malaria in non-endemic areas. Malar J. 2018;17:36. doi: 10.1186/s12936-018-2181-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Bird EM, Parameswaran U, William T, et al. Transfusion-transmitted severe Plasmodium knowlesi malaria in a splenectomized patient with beta-thalassaemia major in Sabah, Malaysia: a case report. Malar J. 2016;15:357. doi: 10.1186/s12936-016-1398-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Prashanth GP, Maralihalli MB, Bagalkot PS, Joshi SN. Intravenous artesunate for transfusion-transmitted plasmodium vivax malaria in a preterm neonate. Pediatrics. 2012;130:e706–9. doi: 10.1542/peds.2011-2023. [DOI] [PubMed] [Google Scholar]
  • 78.Echeverri D, Barreto DK, Osorio L, Cortés A, Martínez E. Malaria por Plasmodium vivax transmitida por transfusión de un donante asintomático a un recién nacido prematuro (A case report of transfusion-transmitted Plasmodium vivax malaria from an asymptomatic donor to a premature newborn) biomedica. 2012;32(Suppl 1):8–12. doi: 10.1590/S0120-41572012000500002. [DOI] [PubMed] [Google Scholar]
  • 79.Nolte K, Stibbe W, Kuhlencord A, Bommer W, Gallasch E. Transfusionsbedingte Malaria tropica. Beitr Infusionstherapie Klin Ernähr. 1987;18:42–46. [PubMed] [Google Scholar]
  • 80.Schunkert H, Handt S, de Wit M, Gladziwa U, Glöckner W, Sieberth H. Transfusionsmalaria bei Promyelozytenleukämie. Dtsch Med Wochenschr. 1988;113:1841–1843. doi: 10.1055/s-2008-1067898. [DOI] [PubMed] [Google Scholar]
  • 81.Witt O, Iglauer ARJ, Bommer W, Eber S. Transfusionsmalaria als Ursache von unklarem postoperativen Fieber. Monatsschrift Kinderheilkd. 1998;146:1054–1056. doi: 10.1007/s001120050363. [DOI] [Google Scholar]
  • 82.Faruk JA, Ogunrinde GO, Mamman AI. Observation of Blood Donor-Recipient Malaria Parasitaemia Patterns in a Malaria Endemic Region. J Trop Med. 2017;2017:7149261. doi: 10.1155/2017/7149261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Iheonu FO, Fajolu IB, Ezeaka CV, Oyibo WA. Transfusional malaria in the neonatal period in Lagos, South-West Nigeria. PLoS ONE. 2018;13:e195319. doi: 10.1371/journal.pone.0195319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Freimanis G, Sedegah M, Owusu-Ofori S, Kumar S, Allain J-P. Investigating the prevalence of transfusion transmission of Plasmodium within a hyperendemic blood donation system. Transfusion. 2013;53:1429–1441. doi: 10.1111/j.1537-2995.2012.03943.x. [DOI] [PubMed] [Google Scholar]
  • 85.Owusu-Ofori A, Gadzo D, Bates I. Transfusion-transmitted malaria: donor prevalence of parasitaemia and a survey of healthcare workers knowledge and practices in a district hospital in Ghana. Malar J. 2016;15:234. doi: 10.1186/s12936-016-1289-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Owusu-Ofori AK, Betson M, Parry CM, Stothard JR, Bates I. Transfusion-transmitted malaria in Ghana. Clin Infect Dis. 2013;56:1735–1741. doi: 10.1093/cid/cit130. [DOI] [PubMed] [Google Scholar]
  • 87.Owusu-Ofori AK, Parry C, Bates I. Transfusion-transmitted malaria in countries where malaria is endemic: a review of the literature from sub-Saharan Africa. Clin Infect Dis. 2010;51:1192–1198. doi: 10.1086/656806. [DOI] [PubMed] [Google Scholar]
  • 88.Faruk JA. Blood transfusion malaria: A literature review. Ann Niger Med. 2016;10:49. doi: 10.4103/0331-3131.206210. [DOI] [Google Scholar]
  • 89.Núñez L, Linares J, Pérez AH. Seroprevalencia de anticuerpos a Plasmodium falciparum en donantes voluntarios de varias ciudades de Venezuela (Seroprevalence of antibodies against Plasmodium falciparum in volunteer donors from various cities in Venezuela) Sangre (barc) 1992;37(2):141–143. [PubMed] [Google Scholar]
  • 90.Okocha EC, Ibeh CC, Ele PU, Ibeh NC. The prevalence of malaria parasitaemia in blood donors in a Nigerian teaching hospital. J Vector Borne Dis. 2005;42(1):21–24. [PubMed] [Google Scholar]
  • 91.Antwi-Baffour S, Kyeremeh R, Amoako AP, Annison L, Tetteh JO-M, Seidu MA. The Incidence of Malaria Parasites in Screened Donor Blood for Transfusion. Malar Res Treat. 2019;2019:1457406. doi: 10.1155/2019/1457406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Murphy KJ, Conroy AL, Ddungu H, et al. Malaria parasitemia among blood donors in Uganda. Transfusion. 2020;60:955–964. doi: 10.1111/trf.15775. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93.Bruce-Chwatt LJ. Transfusion malaria. Bull World Health Organ. 1974;50(3–4):337–346. [PMC free article] [PubMed] [Google Scholar]
  • 94.Benito A, Rubio JM. Usefulness of seminested polymerase chain reaction for screening blood donors at risk for malaria in Spain. Emerging Infect Dis. 2001;7:1068. doi: 10.3201/eid0706.010632. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Rocha D, de Melo GC, Carneiro JMH, et al. Use of a NAT-based assay to improve the surveillance system and prevent transfusion-transmitted malaria in blood banks. Malar J. 2020;19:275. doi: 10.1186/s12936-020-03345-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Chiodini PL, Hartley S, Hewitt PE, et al. Evaluation of a malaria antibody ELISA and its value in reducing potential wastage of red cell donations from blood donors exposed to malaria, with a note on a case of transfusion-transmitted malaria. Vox Sang. 1997;73:143–148. doi: 10.1046/j.1423-0410.1997.7330143.x. [DOI] [PubMed] [Google Scholar]
  • 97.Elghouzzi M-H, Senegas A, Steinmetz T, et al. Multicentric evaluation of the DiaMed enzyme-linked immunosorbent assay malaria antibody test for screening of blood donors for malaria. Vox Sang. 2008;94:33–40. doi: 10.1111/j.1423-0410.2007.00998.x. [DOI] [PubMed] [Google Scholar]
  • 98.Grande R, Petrini G, Silvani I, Simoneschi B, Marconi M, Torresani E. Immunological testing for malaria and blood donor deferral: the experience of the Ca’ Granda Polyclinic Hospital in Milan. Blood Transfus. 2011;9:162–166. doi: 10.2450/2011.0158-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99.O’Brien SF, Ward S, Gallian P, et al. Malaria blood safety policy in five non-endemic countries: a retrospective comparison through the lens of the ABO risk-based decision-making framework. Blood Transfus. 2019;17:94–102. doi: 10.2450/2019.0222-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100.Maire F, Gallian P, Houze S, Resch E, Corbi C, Ribon N, Jbilou S, Narbey D, Courbil R. A propos d’un cas de paludisme post-transfusionnel. France: Clermont-Ferrand; 2013. [Google Scholar]
  • 101.Kitchen AD, Chiodini PL, Tossell J. Detection of malarial DNA in blood donors—evidence of persistent infection. Vox Sang. 2014;107:123–131. doi: 10.1111/vox.12142. [DOI] [PubMed] [Google Scholar]
  • 102.Seed CR, Kee G, Wong T, Law M, Ismay S. Assessing the safety and efficacy of a test-based, targeted donor screening strategy to minimize transfusion transmitted malaria. Vox Sang. 2010;98:e182–92. doi: 10.1111/j.1423-0410.2009.01251.x. [DOI] [PubMed] [Google Scholar]
  • 103.Seed CR, Coughlin JT, Pickworth AM, Harley RJ, Keller AJ. Relapsing vivax malaria despite chemoprophylaxis in two blood donors who had travelled to Papua New Guinea. Med J Aust. 2010;192:471–473. doi: 10.5694/j.1326-5377.2010.tb03590.x. [DOI] [PubMed] [Google Scholar]
  • 104.WHO (2021) WHO recommends groundbreaking malaria vaccine for children at risk. Historic RTS,S/AS01 recommendation can reinvigorate the fight against malaria, Geneva
  • 105.FDA (2020) Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria
  • 106.Bundesärztekammer (2017) Richtlinie zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten (Richtlinie Hämotherapie)
  • 107.Nowak-Harnau S, Hering B, Mordmüller B, Bakchoul T. Prävention der Ãœbertragung von Malariaerregern durch Bluttransfusion: ein Update über die Diagnostik und Spendertestung. Transfusionsmedizin. 2020;10:29–34. doi: 10.1055/a-0981-1799. [DOI] [Google Scholar]
  • 108.Houareau C, Deitenbeck R, Sümnig A, et al. Good Feasibility of the New German Blood Donor Questionnaire. Transfus Med Hemother. 2017;44:232–239. doi: 10.1159/000477942. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 109.Leiby DA, Nguyen ML, Notari EP. Impact of donor deferrals for malaria on blood availability in the United States. Transfusion. 2008;48:2222–2228. doi: 10.1111/j.1537-2995.2008.01825.x. [DOI] [PubMed] [Google Scholar]
  • 110.Nguyen ML, Goff T, Gibble J, Steele WR, Leiby DA. Analyzing actual risk in malaria-deferred donors through selective serologic testing. Transfusion. 2013;53:1736–1743. doi: 10.1111/trf.12004. [DOI] [PubMed] [Google Scholar]
  • 111.Spencer B, Steele W, Custer B, et al. Risk for malaria in United States donors deferred for travel to malaria-endemic areas. Transfusion. 2009;49:2335–2345. doi: 10.1111/j.1537-2995.2009.02290.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 112.U.S. Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research (2020) Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria. Guidance for Industry
  • 113.El Chaar M, Atwal S, Freimanis GL, Dinko B, Sutherland CJ, Allain J-P. Inactivation of Plasmodium falciparum in whole blood by riboflavin plus irradiation. Transfusion. 2013;53:3174–3183. doi: 10.1111/trf.12235. [DOI] [PubMed] [Google Scholar]
  • 114.Allain J-P, Owusu-Ofori AK, Assennato SM, Marschner S, Goodrich RP, Owusu-Ofori S. Effect of Plasmodium inactivation in whole blood on the incidence of blood transfusion-transmitted malaria in endemic regions: the African Investigation of the Mirasol System (AIMS) randomised controlled trial. Lancet. 2016;387:1753–1761. doi: 10.1016/S0140-6736(16)00581-X. [DOI] [PubMed] [Google Scholar]
  • 115.Owusu-Ofori S, Kusi J, Owusu-Ofori A, et al. Treatment of Whole Blood With Riboflavin and UV Light: Impact on Malaria Parasite Viability and Whole Blood Storage. Shock. 2015;44(Suppl 1):33–38. doi: 10.1097/SHK.0000000000000280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 116.Grellier P, Santus R, Mouray E, et al. Photosensitized inactivation of Plasmodium falciparum- and Babesia divergens-infected erythrocytes in whole blood by lipophilic pheophorbide derivatives. Vox Sang. 1997;72:211–220. doi: 10.1046/j.1423-0410.1997.7240211.x. [DOI] [PubMed] [Google Scholar]
  • 117.Lustigman S, Ben-Hur E. Photosensitized inactivation of Plasmodium falciparum in human red cells by phthalocyanines. Transfusion. 1996;36:543–546. doi: 10.1046/j.1537-2995.1996.36696269514.x. [DOI] [PubMed] [Google Scholar]
  • 118.Keil SD, Kiser P, Sullivan JJ, et al. Inactivation of Plasmodium spp. in plasma and platelet concentrates using riboflavin and ultraviolet light. Transfusion. 2013;53:2278–2286. doi: 10.1111/trf.12079. [DOI] [PubMed] [Google Scholar]
  • 119.Ware AD, Jacquot C, Tobian AAR, Gehrie EA, Ness PM, Bloch EM. Pathogen reduction and blood transfusion safety in Africa: strengths, limitations and challenges of implementation in low-resource settings. Vox Sang. 2018;113:3–12. doi: 10.1111/vox.12620. [DOI] [PubMed] [Google Scholar]
  • 120.Smith TG, Kain KC. Inactivation of Plasmodium falciparum by photodynamic excitation of heme-cycle intermediates derived from delta-aminolevulinic acid. J Infect Dis. 2004;190:184–191. doi: 10.1086/421503. [DOI] [PubMed] [Google Scholar]
  • 121.Ferreira-da-Cruz Md F, Teva A, et al. Inactivation of Plasmodium falciparum parasites using gamma-irradiation. Mem Inst Oswaldo Cruz. 1997;92:137–138. doi: 10.1590/s0074-02761997000100029. [DOI] [PubMed] [Google Scholar]
  • 122.Singh Y, Sawyer LS, Pinkoski LS, et al. Photochemical treatment of plasma with amotosalen and long-wavelength ultraviolet light inactivates pathogens while retaining coagulation function. Transfusion. 2006;46:1168–1177. doi: 10.1111/j.1537-2995.2006.00867.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 123.Sow C, Laughhunn A, Girard YA, et al. Inactivation of Plasmodium falciparum in whole blood using the amustaline and glutathione pathogen reduction technology. Transfusion. 2020;60:799–805. doi: 10.1111/trf.15734. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 124.Butler EK, McCullough J. Pathogen reduction combined with rapid diagnostic tests to reduce the risk of transfusion-transmitted infections in Uganda. Transfusion. 2018;58:854–861. doi: 10.1111/trf.14497. [DOI] [PubMed] [Google Scholar]
  • 125.Kleinman S, Stassinopoulos A. Risks associated with red blood cell transfusions: potential benefits from application of pathogen inactivation. Transfusion. 2015;55:2983–3000. doi: 10.1111/trf.13259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 126.Mitteilungen des Arbeitskreises Blut des Bundesministeriums für Gesundheit Pathogen-Inaktivierungssysteme für Thrombozytenkonzentrate : Stellungnahme. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018;61:874–893. doi: 10.1007/s00103-018-2766-3. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz are provided here courtesy of Nature Publishing Group

RESOURCES